India’s pharmaceutical industry has emerged as a global powerhouse, supplying affordable and high-quality medications worldwide. Among the top drug manufacturing companies in India, Glenvox Biotech Company stands out for its commitment to excellence and innovation.
Established in 2015, Glenvox Biotech Company has rapidly ascended to prominence in India’s pharmaceutical landscape. Headquartered in Chandigarh, this ISO-certified company specializes in allopathic medicines and offers PCD (Propaganda Cum Distribution) pharma franchises across the nation.
Glenvox Biotech is renowned for its extensive product portfolio, encompassing tablets, capsules, syrups, injectables, and more. Their unwavering dedication to quality is evident through their WHO-GMP-approved manufacturing processes, ensuring that every product meets international standards. By fostering strong relationships with wholesalers and retailers, Glenvox Biotech has established a robust distribution network, making healthcare accessible to all. This strong focus on distribution sets them apart as one of the top drug manufacturing companies in India.
Contact Us Glenvox Biotech Pvt. Ltd
Sun Pharmaceutical Industries Ltd. is India’s largest pharmaceutical company, with a market capitalization of ₹4.19 lakh crore as of February 2025. Founded in 1983 and headquartered in Mumbai, Sun Pharma manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States. As one of the top drug manufacturing companies in India, Sun Pharma’s product portfolio includes generics, branded generics, specialty, over-the-counter (OTC) products, antiretrovirals (ARVs), APIs, and intermediates. Their commitment to research and development has positioned them as a leader in the global pharmaceutical industry.
Based in Hyderabad, Divi’s Laboratories Ltd. is a prominent player in the pharmaceutical industry, specializing in the manufacture of generic APIs, nutraceutical ingredients, and custom synthesis of active ingredients for global innovator companies. With a market capitalization of ₹1.49 lakh crore, Divi’s is recognized for its world-class manufacturing facilities and stringent quality control measures. Their focus on sustainable practices and innovation has earned them a reputable position among the top drug manufacturing companies in India.
Cipla Ltd., headquartered in Mumbai, has been a stalwart in the Indian pharmaceutical industry since its inception in 1935. With a market capitalization of ₹1.16 lakh crore, Cipla is dedicated to providing affordable and accessible medicines across various therapeutic segments, including respiratory, anti-retroviral, urology, cardiology, and CNS. The company’s global footprint spans over 80 countries, making it one of the top drug manufacturing companies in India. Cipla’s 46 manufacturing sites, producing more than 50 dosage forms, demonstrate their capacity to meet the ever-growing demand for quality healthcare worldwide.
Ahmedabad-based Torrent Pharmaceuticals Ltd. boasts a market capitalization of ₹1.08 lakh crore. The company specializes in the therapeutic areas of cardiovascular, central nervous system, gastroenterology, diabetology, and anti-infective segments. As one of the top drug manufacturing companies in India, Torrent Pharma’s state-of-the-art manufacturing facilities and emphasis on research and development have propelled its growth in both domestic and international markets. Their commitment to quality and innovation has made them a preferred partner for healthcare professionals and patients alike.
Dr. Reddy’s Laboratories Ltd., headquartered in Hyderabad, has a market capitalization of ₹1.00 lakh crore. The company offers a diverse portfolio of products and services, including APIs, generics, biosimilars, and differentiated formulations. Dr. Reddy’s is committed to accelerating access to affordable and innovative medicines, with a presence in markets like the USA, India, Russia, and CIS countries. Their robust research and development infrastructure and focus on sustainability underscore their mission to improve global health outcomes, further reinforcing their status among the top drug manufacturing companies in India.
Formerly known as Cadila Healthcare, Zydus Lifesciences Ltd. is based in Ahmedabad and has a market capitalization of ₹0.98 lakh crore. As one of the top drug manufacturing companies in India, Zydus Lifesciences is a fully integrated, global healthcare provider, offering a spectrum of products ranging from APIs to formulations and wellness products. Zydus is recognized for its strong research capabilities, with several new molecular entities in various stages of development. Their commitment to innovation and healthcare excellence has made them a significant contributor to the pharmaceutical industry.
Delhi-based Mankind Pharma Ltd. has a market capitalization of ₹1.02 lakh crore. The company offers a diverse range of products across various therapeutic areas, including antibiotics, antifungals, gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications. As one of the top drug manufacturing companies in India, Mankind Pharma’s focus on affordability and accessibility has enabled it to establish a strong presence in both urban and rural markets. Their dedication to corporate social responsibility and ethical practices further enhances their reputation in the industry.
Lupin Ltd., headquartered in Mumbai, is a significant player in the pharmaceutical industry with a market capitalization of ₹0.89 lakh crore. The company specializes in the development and production of a wide range of branded and generic formulations, biotechnology products, and APIs. Lupin’s therapeutic areas of focus include cardiovascular, diabetology, asthma, pediatrics, CNS, GI, anti-infectives, and NSAIDs. Their commitment to research and development, along with a strong global presence, underscores their mission to deliver quality healthcare solutions, placing them among the top drug manufacturing companies in India.
Aurobindo Pharma Ltd., based in Hyderabad, is a key player in the global pharmaceutical market. The company specializes in producing high-quality generics, APIs, and branded formulations across various therapeutic segments. Aurobindo’s robust manufacturing infrastructure and strategic global partnerships have earned it a spot among the top drug manufacturing companies in India. Their commitment to innovation, affordability, and accessibility continues to drive their success both in domestic and international markets.
